Form 4 for PHIO Phio Pharmaceuticals Corp.
Accepted 2023-06-15 00:00:00 ET · period of report 2023-06-14 · accession 0001209191-23-037408 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-15 | 2023-06-14 | PHIO | Ferrara Robert L | Dir | P - Purchase | $3.10 | +2,000 | 6,000 | +50% | +$6,200 |
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, $0.0001 par value | 2023-06-14 | P | A | 2,000 | $3.10 | 6,000 | D | — | — | (F1) Includes shares of common stock underlying unvested restricted stock units. |